Scarica l'app Stockscreener
20.45
139.78%
11.93
Precedente Chiudi:
$8.52
Aprire:
$26.455
Volume 24 ore:
75.33M
Relative Volume:
33.37
Capitalizzazione di mercato:
$584.98M
Reddito:
-
Utile/perdita netta:
$-96.66M
Rapporto P/E:
-9.5116
EPS:
-2.15
Flusso di cassa netto:
$-83.73M
1 W Prestazione:
+149.44%
1M Prestazione:
+118.26%
6M Prestazione:
+333.74%
1 anno Prestazione:
+136.72%
Intervallo 1D:
$18.11
$27.17
Intervallo di 1 settimana:
$7.82
$27.17
Portata 52W:
$2.86
$27.17
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Nome
Olema Pharmaceuticals Inc
Settore
Industria
Telefono
(415) 651-3316
Indirizzo
780 BRANNAN STREET, SAN FRANCISCO
Confronta OLMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
20.41 | 584.98M | 0 | -96.66M | -83.73M | -2.15 |
|
ARGX
Argen X Se Adr
|
921.80 | 57.24B | 3.06B | 1.28B | 447.35M | 19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
436.65 | 110.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
INSM
Insmed Inc
|
203.00 | 42.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
ONC
Beone Medicines Ltd Adr
|
365.62 | 41.68B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.34 | 74.02B | 14.25B | 4.58B | 3.88B | 41.77 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-08 | Iniziato | Guggenheim | Buy |
| 2025-08-12 | Reiterato | Citigroup | Buy |
| 2024-04-02 | Iniziato | Goldman | Buy |
| 2024-01-30 | Iniziato | Citigroup | Buy |
| 2023-07-21 | Iniziato | Oppenheimer | Outperform |
| 2023-05-05 | Iniziato | CapitalOne | Overweight |
| 2023-02-22 | Iniziato | Credit Suisse | Outperform |
| 2022-07-06 | Ripresa | Canaccord Genuity | Buy |
| 2022-06-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | Iniziato | H.C. Wainwright | Neutral |
| 2021-12-07 | Ripresa | Cowen | Outperform |
| 2020-12-14 | Iniziato | Canaccord Genuity | Buy |
| 2020-12-14 | Iniziato | Cowen | Outperform |
| 2020-12-14 | Iniziato | JP Morgan | Overweight |
| 2020-12-14 | Iniziato | Jefferies | Buy |
Mostra tutto
Olema Pharmaceuticals Inc Borsa (OLMA) Ultime notizie
Olema Pharmaceuticals, Inc. $OLMA Holdings Raised by Persistent Asset Partners Ltd - MarketBeat
How sustainable is Olema Pharmaceuticals Inc. stock dividend payoutChart Signals & Free Fast Gain Swing Trade Alerts - newser.com
Can Olema Pharmaceuticals Inc. stock double in next 5 yearsAnalyst Downgrade & Stepwise Entry and Exit Trade Signals - newser.com
Forecasting Olema Pharmaceuticals Inc. price range with options dataJuly 2025 Summary & Expert Approved Trade Ideas - newser.com
What Fibonacci levels say about Olema Pharmaceuticals Inc. reboundWeekly Stock Recap & High Return Stock Watch Alerts - newser.com
News impact scoring models applied to Olema Pharmaceuticals Inc.Portfolio Return Summary & Detailed Earnings Play Alerts - newser.com
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 6.3%Time to Buy? - MarketBeat
Sector ETF performance correlation with Olema Pharmaceuticals Inc.Trend Reversal & High Conviction Trade Alerts - newser.com
What Wall Street predicts for Olema Pharmaceuticals Inc. stock pricePortfolio Profit Report & Community Verified Watchlist Alerts - Fundação Cultural do Pará
How to build a dashboard for Olema Pharmaceuticals Inc. stockBreakout Watch & Verified High Yield Trade Plans - newser.com
FY2025 Earnings Estimate for OLMA Issued By Lifesci Capital - MarketBeat
Analysts Set Expectations for OLMA FY2025 Earnings - MarketBeat
Will Olema Pharmaceuticals Inc. stock rally after Fed decisionsJuly 2025 Update & Stepwise Trade Signal Guides - Fundação Cultural do Pará
Olema Pharmaceuticals Inc. stock momentum explainedTrade Performance Summary & Free Real-Time Market Sentiment Alerts - newser.com
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Down 7.2% After Earnings Miss - MarketBeat
Olema Pharmaceuticals Inc Stock Analysis and ForecastPrice Support Zones & High Profit Market Ideas - earlytimes.in
Why Olema Pharmaceuticals Inc. stock could rally in 2025Trade Volume Summary & Safe Entry Zone Tips - newser.com
Olema Pharmaceuticals (NASDAQ:OLMA) Releases Earnings Results, Misses Estimates By $0.05 EPS - MarketBeat
Olema Pharmaceuticals Reports Increased Losses Amid R&D Expansion - TipRanks
Will Olema Pharmaceuticals Inc. continue its uptrend2025 Investor Takeaways & Weekly High Momentum Picks - newser.com
Olema Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Olema Oncology (OLMA) Advances Cancer Treatment Trials - GuruFocus
Olema Pharma Q3 net loss widens - MarketScreener
[10-Q] Olema Pharmaceuticals, Inc. Quarterly Earnings Report | OLMA SEC FilingForm 10-Q - Stock Titan
[8-K] Olema Pharmaceuticals, Inc. Reports Material Event | OLMA SEC FilingForm 8-K - Stock Titan
Olema (NASDAQ: OLMA) reports $329M cash, starts OPERA-02 and Pfizer combo study - Stock Titan
Will Olema Pharmaceuticals Inc. stock go up soonTrade Performance Summary & Free Real-Time Market Sentiment Alerts - newser.com
Has Olema Pharmaceuticals Inc. found a price floorQuarterly Profit Report & AI Powered Market Trend Analysis - newser.com
How geopolitical tensions affect Olema Pharmaceuticals Inc. stock2025 Historical Comparison & AI Powered Buy and Sell Recommendations - newser.com
Why Olema Pharmaceuticals Inc. stock is in analyst buy zoneJuly 2025 Sector Moves & Real-Time Volume Surge Alerts - newser.com
How Olema Pharmaceuticals Inc. stock performs in weak economyJuly 2025 Opening Moves & Fast Momentum Stock Entry Tips - fcp.pa.gov.br
Olema Pharmaceuticals, Inc. (OLMA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Olema Pharmaceuticals (OLMA) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Is Olema Pharmaceuticals Inc. stock ready for breakoutInsider Buying & Weekly Market Pulse Alerts - newser.com
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Olema Pharmaceuticals Inc Azioni (OLMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Olema Pharmaceuticals Inc Azioni (OLMA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Harmon Cyrus | Director |
Sep 16 '25 |
Sale |
8.04 |
10,000 |
80,400 |
754,140 |
| Harmon Cyrus | Director |
Sep 18 '25 |
Sale |
8.32 |
3,086 |
25,676 |
117,028 |
| Harmon Cyrus | Director |
Sep 16 '25 |
Sale |
8.08 |
1,914 |
15,465 |
120,114 |
0.01%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):